Overview

Investigation of Ascending Concentrations of Glycopyrronium Bromide (GPB) in a Topical Formulation in Subjects With Axillary Hyperhidrosis

Status:
Completed

Trial end date:
2017-07-01

Target enrollment:

Participant gender:

Summary

The aim of the study is to assess the safety, tolerability, pharmacokinetics (PK) and efficacy of escalating concentrations of GPB in subjects with axillary hyperhidrosis.

Phase:

Phase 1

Details

Lead Sponsor:

Dr. August Wolff GmbH & Co. KG Arzneimittel

Collaborators:

Charles River Biopharmaceutical Services GmbH
FGK Clinical Research GmbH
Nuvisan GmbH

Treatments:

Bromides
Glycopyrrolate